Volta Labs Launches With $20 Million In Series A

Mar 17, 2022•over 3 years ago

Amount Raised

$20 Million

Round Type

series a

BostonBiotechnologySoftware

Description

Volta Labs, a bioautomation company developing solutions to streamline the upstream workflows in genomic sequencing, today announced it raised $20 million in a Series A funding. The round was led by Maverick Ventures, with participation from Illumina co-founder John Stuelpnagel, Khosla Ventures, Casdin Capital, E14 Funds, Blindspot Ventures and several experienced industry executives. The company has raised over $25M in funding to date.

Company Information

Company

Volta Labs

Location

Boston, Massachusetts, United States

About

Volta Labs is a bioautomation company developing disruptive solutions to streamline the upstream workflows in genomic sequencing. Volta is building a sequencer agnostic platform for sample preparation. We are reinventing the full-stack – hardware, software, chemistry, and biology – to create a simple and flexible platform spanning applications in sample preparation and beyond. The company was founded in 2018 by CEO Udayan Umapathi and later added Will Langford, Head of Engineering, as a co-founder of Volta Labs.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Volta Labs Launches With $20 Million In Series A

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information